Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mass balance and absolute oral bioavailability study of [14C]VH4524184
NL-OMON61135Phase 1Completed
- Sponsor
- ViiV Healthcare
- Start
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, single-arm trial of VH4524184 in human immunodeficiency virus infection (HIV), sponsored by ViiV Healthcare. Started Jun 2026; status: completed.
02
Drugs
VH4524184
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NL-OMON61135.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON61135.